RelA/NF-κB transcription factor associates with α-actinin-4

Autor: Babakov, Vladimir N., Petukhova, Olga A., Turoverova, Lidia V., Kropacheva, Irina V., Tentler, Dmitri G., Bolshakova, Anastasia V., Podolskaya, Ekaterina P., Magnusson, Karl-Eric, Pinaev, George P.

Publikováno v: In Experimental Cell Research 2008 314(5):1030-1038

Correction: Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB (vol 4, pg 362, 2013)

Autor: Aksenova, Vasilisa, Turoverova, Lidia, Khotin, Mikhail, Magnusson, Karl-Eric, Tulchinsky, Eugene, Melino, Gerry, Pinaev, George P, Barlev, Nickolai, Tentler, Dmitri

[This corrects the article DOI: 10.18632/oncotarget.901.].

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c00af9c8536f8913325d94f9ebaba7da
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-156018

Proteomic analysis of ACTN4-interacting proteins reveals it’s a putative involvement in mRNA metabolism

Autor: Khotin, Mikhail, Turoverova, Lidia, Aksenova, Vasilisa, Barlev, Nikolai, Borutinskaite, Veronika Viktorija, Vener, Alexander, Bajenova, Olga, Magnusson, Karl-Eric, Pinaev, George P., Tentler, Dmitri

Publikováno v: In Biochemical and Biophysical Research Communications 25 June 2010 397(2):192-196

Erratum: Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB.

Autor: Aksenova V; Institute of Cytology, Russian Academy of Sciences, Tikhoretsky av., 4, St. Petersburg, Russia.; Laboratory of Molecular Pharmacology, Saint-Petersburg Technological Institute, 26 Moskovsky Prospect, St. Petersburg, Russia., Turoverova L; Institute of Cytology, Russian Academy of Sciences, Tikhoretsky av., 4, St. Petersburg, Russia., Khotin M; Institute of Cytology, Russian Academy of Sciences, Tikhoretsky av., 4, St. Petersburg, Russia., Magnusson KE; Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linköping University, SE-581 85 Linköping, Sweden., Tulchinsky E; Department of Cancer Studies and Molecular Medicine, University of Leicester, RKCSB, LRI, Leicester, UK., Melino G; Laboratory of Molecular Pharmacology, Saint-Petersburg Technological Institute, 26 Moskovsky Prospect, St. Petersburg, Russia.; MRC Toxicology Unit, Leicester, UK., Pinaev GP; Institute of Cytology, Russian Academy of Sciences, Tikhoretsky av., 4, St. Petersburg, Russia., Barlev N; Institute of Cytology, Russian Academy of Sciences, Tikhoretsky av., 4, St. Petersburg, Russia.; Laboratory of Molecular Pharmacology, Saint-Petersburg Technological Institute, 26 Moskovsky Prospect, St. Petersburg, Russia.; Department of Biochemistry, University of Leicester, Lancaster Road, Leicester, UK., Tentler D; Institute of Cytology, Russian Academy of Sciences, Tikhoretsky av., 4, St. Petersburg, Russia.; Laboratory of Molecular Pharmacology, Saint-Petersburg Technological Institute, 26 Moskovsky Prospect, St. Petersburg, Russia.

Publikováno v: Oncotarget [Oncotarget] 2018 Sep 28; Vol. 9 (76), pp. 34450. Date of Electronic Publication: 2018 Sep 28 (Print Publication: 2018).